Futuragene Share Discussion Threads

[leadersoffice] 09/3/2006 17:16

Futuragene Plc Additional Listing
RNS Number:5635Z
Futuragene PLC
09 March 2006


FUTURAGENE PLC (the "Company")

Additional Listing

Application has been made for 3,000,000 ordinary shares of 0.5p each in the
Company ("Ordinary Shares") to be admitted to trading on the AIM market of the
London Stock Exchange ("AIM"). These shares rank pari passu with the Company's
existing Ordinary Shares and dealings are expected to commence on 15 March 2006
on AIM.

The new Ordinary Shares are being issued to the vendors of FuturaGene, Inc
pursuant to the terms of the merger agreement dated 20 May 2004 used to effect
the reverse takeover of FuturaGene, Inc by the Company. Under the terms of this
agreement, the Company agreed to allot, issue or pay, as appropriate, to the
shareholders of FuturaGene Inc. either (a) an additional 3,000,000 Ordinary
Shares, or (b) the sum of the US dollar equivalent of #1.14 million in cash. The
determining factor as to whether this additional consideration would be payable
in Ordinary Shares was agreed to be the acceptance by the United States Inland
Revenue Service that the exchange of Ordinary Shares in the Company for shares
in FuturaGene, Inc qualifies as a tax free reorganisation under the United
States Internal Revenue Code 1986.

The Company has now received confirmation from the United States Inland Revenue
Service that the exchange of Ordinary Shares in the Company for shares in
FuturaGene, Inc does qualifies as a tax free reorganisation under the United
States Internal Revenue Code 1986 and has therefore satisfied the outstanding
consideration by the issue of the above Ordinary Shares.

As a result of the issue of the above Ordinary Shares to the shareholders of
FuturaGene, Inc, the following directors of the Company have increased their
holding in the issued share capital of the Company:

Director Number of new Number of new Percentage of
Ordinary Shares Ordinary Shares the enlarged
received held following issued share
the issue capital held
following the
issue

Mark Pritchard 375,018 2,375,117 6.23%
Marta Zgagacz 88,797 562,380 1.48%
9 March 2006

For further information, please contact:

FuturaGene Plc
Mark Pritchard, Chairman [phone]

Cubitt Consulting
Michael Henman [phone]




This information is provided by RNS
The company news service from the London Stock Exchange

END
LISAKCKQBBKDDNK

[leadersoffice] 08/3/2006 16:51

I think MM's are trying to scare investors into selling so they can gather stock...has to be. dyor

[harry punter] 08/3/2006 10:45

buy on weakness --this is an outstanding bargain --its not short term

[harry punter] 07/3/2006 13:49

relaxing in the paddock leader

[leadersoffice] 07/3/2006 13:31

MMMM
Wats going on ere then???????

[harry punter] 17/2/2006 18:44

off topic---------these are well worth buying for a take over north of 30p imho --taking a 3 month view

International Brand Licensing chairman Adam Reynolds buys shares at 18.5p
LONDON (AFX) - International Brand Licensing PLC said its chairman, Adam
Reynolds, has bought 100,000 ordinary shares in the company at 18.5 pence and
now holds 100,000 shares at 1 pence, representing approximately 0.3 pct.

[e-mail]
vjt

International Brand Licensing Plc

New European Strategic Partnership

International Brand Licensing Plc ("IBL"), owner of the Admiral sportswear
brand, announces a new strategic alliance with @miral BV for the territory of
Benelux, Germany, Austria, and Switzerland.

As part of a ten, plus five year option, license agreement for this key central
European territory, @miral will use its extensive design, development, and
marketing resources to develop seasonal programmes for IBL's network of
international licensees. Sales revenues in the @miral territory are forecast to
total over EUR 60,000,000 through the initial term. As part of the agreement
@miral will be granted 250,000 shares in IBL together with a further 650,000
share options at 18.50p exercisable over five years from date of grant.

IBL Chief Executive, Tony Hutchinson, comments: "We are delighted to have
signed this new agreement with @miral. Not only will this significantly
accelerate Admiral's growth in @miral's own territory, but their extensive and
talented product and marketing resources will be of major benefit to all
Admiral licensees worldwide."

Admiral is the official kit sponsor of the England and West Indies cricket
teams and Leeds United, and is sold at ASDA stores and sports independents
throughout the UK.

For further information contact:

Tony Hutchinson

Adam Reynolds

IBL plc

Tel: [phone]

[harry punter] 17/2/2006 12:05

stock overhang is getting cleared - leader -- soon we will get an annoucement - imho \o/ then we will be off to the races \o/

[harry punter] 17/2/2006 11:56

shares will be back up to one pound fifty plus soon \o/

[harry punter] 17/2/2006 11:00

i have just bought some more to average \o/

[brownmruk] 17/2/2006 10:13

Anyone know what is driving this? Volumes don't look enough to justify rise.

OK - seeing the reaction to the sales, maybe it was just the volume.

[rosco46] 17/2/2006 10:11

I think FGN are now back on the road to recovery weve heard little from them of late...perhaps some news has been leaked (re:the trials) hence the buying thats going on.... be nice to see them back to 220ish but then if the results are good who knows... the skys the limit. amho
as always dyor
Regards

[leadersoffice] 17/2/2006 08:13

10 p spread on these babies at the moment and 98,000 traded yesterday and no mark up.

Looks like hopefully it up from here!!

Get in EME

[harry punter] 16/2/2006 16:58

fgn looks steady at these levels --i am hearing that these are cheap at this level -- it will soon time to buy i think -

[harry punter] 05/2/2006 12:09

best punt in the market apart from MpM is gtl resources at 2.5p dyor

being advised and told that GTL are certainly going to 5p - with a lot of large institutional buyers being lined up next week -- we shall see dyor

[harry punter] 04/2/2006 08:38

jasper -market makers spread doesnt help -- this is a buy for the longer term on any weakness imho

[jasper23] 03/2/2006 19:10

I'm new to investing in shares, so I appologise for naivety of the following question, but could anyone tell me why with so few apparent trades today (including one for £500000) that Futuragene fell by over 4 points?

[harry punter] 31/1/2006 15:56

EPIC Name Price Change(%)
1 (1) CSH Caspian Hldgs. 25.5 33 A
2 (2) MGTC Martin C.IG CAP 7.75 18
3 (3) LUP Lupus Capital 13.25 14
4 (4) PGD Patagonia GLD 22.5 14
5 (5) OHM Off. Hydro 103.0 13
6 (6) PYC Physiomics 1.025 13
7 (7) MLR Maelor 7.625 12 A
8 (8) PNG Persian Gold 22.5 12
9 (9) FUM Futura Med. 77.25 11
10 (10) SCE Surface Trans 19.0 11
11 (11) EEN Emerald Energy 246.25 11
12 (12) SBG SBS Grp. 104.0 11
13 (13) CEC Creative Educ 1.25 10
14 (14) PDR Premier Direct 162.5 10

harry punter - 31 Jan'06 - 15:55 - 233 of 233 edit


another good tip from harry punter -- sbs group up 11%

[harry punter] 31/1/2006 13:26

any overhang - not the slightest bit worried ---plenty of big punters money backing fgn -\o/

[pugugly] 31/1/2006 13:06

Cautiion. Potentially massive dilution with up to 26 MILLION shares. Source

Lyndus - 14 Oct'04 - 14:37 - 562 of 822

Taken from Terms of the Aquisition Agreement
The company shall pay additional merger consideration by way of further a
adjustment to the Exchange Ratio on the following basis:

(a)6million consideration shares when Futuragen has been granted an EXCLUSIVE
LICENCE OVER THREE NEW GENE DISCOVERIES FOR WHICH PATENT APPLICATIONS HAS BEEN RECEIVED BY US PATENT AND TRADEMARK OFFICE in the names of and as submitted by those Universities with which Futuragene has licensing agreements or other
Universities with which the Scientific Advisory Board are affiliated.

(b)10million consideration shares payable on receipt of a "QUALIFIED OFFER"
from a THIRD PARTY. TO licence any element of the FuturaGene intellectual property.

(c)10million Consideration Shares payable on receipt of an additional
"QUALIFIED OFFER" from a third party to licence any element of the FuturaGene intellectual property.

Hope someone finds this informative. Total 26 million extra shares possible)

[leadersoffice] 31/1/2006 08:36

Futuragene Plc Statement re Licence in China
FuturaGene PLC

FuturaGene Granted 10 Year Business Licence In China

The Board of FuturaGene plc ("FuturaGene" or the Company") is pleased to
announce that the Government of the Peoples Republic of China ("China") has
granted a 10-year business licence to FuturaGene Investment Consulting (Beijing)
Company Limited ("FuturaGene Beijing") a wholly owned subsidiary of the Company.
The grant of the licence follows the establishment of FuturaGene Beijing,
announced at the time of the company's interim announcement at the end of
September last year. Since then the business has been operating under a
temporary licence.

In addition to the current partnership with the Chinese Agriculture University,
the licence would enable FuturaGene to enter into similar partnerships with
other key institutions and laboratories in China. These partnerships will expand
our research and applied development capability, as well as our gene discovery
engine.

This strengthens FuturaGene's position in China, and is an indication to its
partners in China of the long-term potential of its partnership and the
commitment it has made. This long-term business licence allows FuturaGene to
carry out the necessary business activity such as licensing and performing
contract services for our partners, which are crucial to the Company's long-term
growth and future development plans. The Company will also be in a position to
exploit new technologies for both the Chinese market and markets outside of
China.

Kannan Grant, acting CEO of FuturaGene commented:

"We are delighted to have been awarded this licence. The fact that it is for a
longer period than we had initially sought is particularly pleasing and
illustrates the commitment shown by the Company to the Chinese Government and
our commitment to our partners and the opportunities in the region."

31 January 2006

For further details, please contact:
FuturaGene plc
Kannan Grant. Acting CEO, Tel: [phone]


Cubitt Consulting
Michael Henman [phone]

Notes

FuturaGene Plc

FuturaGene is committed to the research and development of environmentally
friendly solutions to solve crop production problems.

FuturaGene Plc. sponsors research at a consortium of universities to develop
knowledge and create intellectual property that is essential to the development
of crop species with enhanced agronomic characteristics including tolerance to a
variety of environmental stress such as salt, drought and cold conditions.
FuturaGene has established contracts with several universities for the exclusive
global commercial rights on a suite of utility and provisional patents.

The Group's technology comprises of a licensed patented portfolio of genes which
enhance the function of genes already present in the plant through over
expression of these genes. FuturaGene has identified genes which confer enhanced
tolerance and enable plants to withstand extreme environmental stresses such as
cold, drought, fungal pathogens and high salt concentrations.

FuturaGene already has laboratory prototypes of rice and tomato plants with
resistance to salt, drought and cold.

The total seed agricultural biotechnology market is estimated to have a value in
the region of $3bn while the total seeds market is estimated to be worth between
$12 and $15bn.

[artful dodger] 31/1/2006 08:35

so it's a gene-play and china!

only needs to drill for oil/minerals and its got the set!